A
ArriVent BioPharma, Inc.
AVBP · NASDAQ · Healthcare · 1.4B
Closing price
$16.73
+0.12% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
-3.6×
Free cash flow yieldFCF yield
-25.0%
Return on equityROE
-54.1%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.